Inocare

Romania Acquired By Horus Pharma
Provider of ophthalmic products for eye surface health and retinal support

About Inocare

Inocare is a Healthcare company based in Romania, and was acquired by Horus Pharma in November 2024. Provider of ophthalmic products for eye surface health and retinal support. Its focus areas include Traditional Pharmaceuticals. Its legal entity is INOCARE PHARM SRL.

Company details

Ophthalmic products focused on eye surface health and retinal support are developed by Inocare in the healthcare sector. Conditions such as dry eye syndrome, eyelid disorders, and retinal pathologies are targeted through these offerings. Collaboration with ophthalmologists informs product design for prevention and treatment purposes. Solutions for cataract patients facing surgical delays or contraindications are also supplied. Availability occurs via pharmacies and online channels, with operations based in Romania.

Key Metrics

Investors in Inocare

Inocare has secured backing from 1 investor. Prominent investors backing the company include Horus Pharma.

All
InvestorDescriptionFounded YearDomainLocation
Ophthalmology pharmaceutical products are developed by Horus Pharma.
2003horus-pharma.com
Premium access

Investor details for Inocare

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Web traffic of Inocare

The website of Inocare (inocare.ro) receives about 1.1K visits a month.

  • Monthly visits
    1.1K

    ▲ 54.2% vs previous month

Similar websites

Websites whose visitors overlap most with Inocare. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
hylo.ro
hylo.ro
100%
#6,502,397–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Inocare

Inocare is headquartered in Romania.

Ophthalmic products focused on eye surface health and retinal support are developed by Inocare in the healthcare sector. Conditions such as dry eye syndrome, eyelid disorders, and retinal pathologies are targeted through these offerings. Collaboration with ophthalmologists informs product design for prevention and treatment purposes. Solutions for cataract patients facing surgical delays or contraindications are also supplied. Availability occurs via pharmacies and online channels, with operations based in Romania.

Inocare has 1 investor. Key investors include Horus Pharma.

Inocare operates through Inocare Pharm Srl.

Yes. Inocare was acquired by Horus Pharma in November 2024.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available